Recurrent ovarian cancer: Is there a role for re-treatment with bevacizumab after an initial complete response to a bevacizumab-containing regimen?

✍ Scribed by Georgia A. McCann; Blair Smith; Floor J. Backes; Kellie Rath; Simi Chacko; Ritu Salani; Eric Eisenhauer; Jeffrey M. Fowler; David E. Cohn; David M. O'Malley

• Book ID: 118506824
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 378 KB
• Volume: 127
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2012.08.001